If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
73.20    1.20 (1.67%)
Bid:
72.00
Ask:
72.80
Spread: 0.80 (1.111%)
Market Cap: £98.80m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Interim Management Statement/Directorate Change

2 Feb 2009 07:00

RNS Number : 6098M
Trifast PLC
02 February 2009
 



TRIFAST PLC

('Trifast' or 'the Company' or 'the Group')

Interim Management Statement

Directorate Change

2 February 2009

Trifast, an international manufacturer and distributor of industrial fasteners and components today announces its interim management statement for its third quarter, the three months ended 31 December 2008, and a directorate change.

Interim Management Statement

Overall the Group's revenues and profitability have been impacted by the rapid onset of recession in Europe and North America and profits before taxation (before intangible amortisation, IFRS2 charges and impairment of associated company) are therefore expected to be below market expectations.

The third quarter trading period has seen revenue reductions in the UK, Turkey and our Scandinavian business units largely resulting from reductions in demand from both the automotive sub-contract manufacturing base and domestic appliance base. Our activities in Holland, Germany, Hungary and Poland have all reported revenue growth. Our planned approach to selling TR manufactured products to distributors in North America is developing well and we now have a number of regional customers and we are hoping to sign up with a national distributor shortly. This will allow us to maintain profitable growth in this region.

The Asian market has performed well in the third quarter and is in line with forecasts and our business activities in the North American market are ahead of our original forecasts. However, it is expected that the recessions in North America and Europe will impact on Asia for our fourth quarter and next financial year due to order cancellations and a reduction in overall demand.

As previously announced at our interim results the Group advised of the loss of a £1 million contract for screw components supplied to the hard disk market in Asia. We are pleased to report we are now receiving new orders and we are expecting to see revenue improvements from this business sector in the next financial year.

The expected impact of the factors described above on profit before taxation (before intangible amortisation, IFRS2 charges and impairment of associated company) for the year ending 31 March 2009 is likely to be as follows: the downturn in the UK and Scandinavia resulting in an expected reduction in the UK of £1.6m and in Sweden of £0.3m, and an expected reduction of £0.2m in Turkey.

In addition the Group expects to report the following exceptional items for the financial year: a £0.9m charge as a result of our ongoing redundancy programme which will result in annualised cost savings of £2.0m, and a stock provisioning and impairment charge of £1.6m for our Turkish operations. Additionally, the long standing settlement of the litigation by Zurich Insurance (as detailed in our Placing and Open Offer document for the acquisition of Serco Ryan in September 2005) will result in a $0.9m settlement cost, previously expected to be $3.9m, being agreed for this financial year.

The impact of the exceptional items outlined above on the Group's cash flow is expected to be £1.5m. Notwithstanding this, Trifast's overall cash flow remains healthy. The Company's working capital requirement is being managed tightly and recent negotiations with our bank have resulted in the Company securing a revised multi-currency revolving credit facility for a term period of three years.

Directorate Change

The Group advises that Stuart Lawson, currently Chief Financial Officer and European Managing Director, will be leaving the Company with effect from 31 January 2009. Steve Auld, Chief Executive Officer, will assume responsibility for the Group's European operations, whilst Mark Belton, Group Financial Controller and Company Secretary, will assume full responsibility for the Company's finance function.

Summary

In this challenging market place Trifast remains focused on cash generation, ensuring costs are under tight control, and positioning the business to compete effectively.

- ENDS -

Enquiries

Trifast Group plc Tel: 01825 747 366

Steve Auld, Chief Executive Officer

Smithfield Consultants

Reg Hoare / Will Swan / Will Henderson Tel: 020 7360 4900

Fairfax I.S. plc

Simon Bennett / Jeremy Porter Tel: 020 7598 5368

For more information please visit www.trifast.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUUQAPUPBUQP
Date   Source Headline
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address
21st Nov 20243:09 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSHALF-YEARLY FINANCIAL REPORT
22nd Oct 20247:00 amRNSTrading update and Notice of Half-year results
12th Sep 20244:21 pmRNSDirector/PDMR Shareholding
10th Sep 20244:48 pmRNSResult of AGM
10th Sep 20247:01 amRNSAGM Statement
10th Sep 20247:00 amRNSAppointment of CFO
27th Aug 20249:21 amRNSProposed new Directors Remuneration Policy
21st Aug 20249:32 amRNSDirector/PDMR Shareholding
15th Aug 202411:40 amRNSHolding(s) in Company
6th Aug 20243:49 pmRNSPurchase of shares
31st Jul 20244:00 pmRNSAvailability of Annual Report & Notice of Meeting
29th Jul 20247:00 amRNSAnnual Results - 31 March 2024 - Annual Report
23rd Jul 20247:00 amRNSFY24 annual results - date confirmation
2nd Jul 20244:43 pmRNSFY24 results publication–revision of release date
11th Jun 20249:24 amRNSAnnual results presentations
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.